Kidney transcriptomics signature of prospective rapid diabetic kidney disease progression
View ORCID ProfileDianne Acoba, View ORCID ProfileAnna Levin, Anna Witasp, Kerstin Ebefors, View ORCID ProfileJohan Mölne, View ORCID ProfilePeter J. Greasley, View ORCID ProfileJenny Nyström, View ORCID ProfileAnnika Wernerson, Anna Reznichenko
doi: https://doi.org/10.1101/2024.07.03.24309831
Dianne Acoba
1Translational Science & Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
2Institut Necker Enfants Malades (INEM), Institut National de la Santé et de la Recherche Médicale (INSERM) U1151, Université Paris Cité, Paris, France
MScAnna Levin
3Department of Clinical Science, Intervention and Technology, Division of Renal Medicine, Karolinska Institutet, Stockholm, Sweden
MDAnna Witasp
3Department of Clinical Science, Intervention and Technology, Division of Renal Medicine, Karolinska Institutet, Stockholm, Sweden
PhDKerstin Ebefors
4Department of Physiology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
PhDJohan Mölne
5Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
MDPeter J. Greasley
6Early Clinical Development, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
PhDJenny Nyström
4Department of Physiology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
PhDAnnika Wernerson
3Department of Clinical Science, Intervention and Technology, Division of Renal Medicine, Karolinska Institutet, Stockholm, Sweden
MD PhDAnna Reznichenko
1Translational Science & Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
MD PhD![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
The raw RNA-seq data analyzed in this study is openly available at http://karokidney.org/rna-seq-dn/.
Posted July 04, 2024.
Kidney transcriptomics signature of prospective rapid diabetic kidney disease progression
Dianne Acoba, Anna Levin, Anna Witasp, Kerstin Ebefors, Johan Mölne, Peter J. Greasley, Jenny Nyström, Annika Wernerson, Anna Reznichenko
medRxiv 2024.07.03.24309831; doi: https://doi.org/10.1101/2024.07.03.24309831
Kidney transcriptomics signature of prospective rapid diabetic kidney disease progression
Dianne Acoba, Anna Levin, Anna Witasp, Kerstin Ebefors, Johan Mölne, Peter J. Greasley, Jenny Nyström, Annika Wernerson, Anna Reznichenko
medRxiv 2024.07.03.24309831; doi: https://doi.org/10.1101/2024.07.03.24309831
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (671)
- Anesthesia (181)
- Cardiovascular Medicine (2661)
- Dermatology (224)
- Emergency Medicine (402)
- Epidemiology (12264)
- Forensic Medicine (10)
- Gastroenterology (765)
- Genetic and Genomic Medicine (4122)
- Geriatric Medicine (387)
- Health Economics (681)
- Health Informatics (2670)
- Health Policy (1008)
- Hematology (364)
- HIV/AIDS (855)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (442)
- Neurology (3912)
- Nursing (210)
- Nutrition (582)
- Oncology (2048)
- Ophthalmology (587)
- Orthopedics (242)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (455)
- Public and Global Health (6551)
- Radiology and Imaging (1410)
- Respiratory Medicine (872)
- Rheumatology (412)
- Sports Medicine (344)
- Surgery (452)
- Toxicology (54)
- Transplantation (186)
- Urology (167)